Start-Ups Swimming ...
Health Care: Health Services
Biolase Inc (BIOL: NASDAQ)
$4.58 -0.19 | -3.98%
05/24/13 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 4.58 |
| 52 Week High | 6.05 |
| 52 Week Low | 1.48 |
| Avg. Daily Vol. (Mil) | 0.47 |
| Beta (3 year) | 2.51 |
| Share Related Items | |
| Mkt Cap (Mil) | 144.63 |
| Shares Out (Mil) | 31.58 |
| Float (Mil) | 29.99 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 0.60 |
| Current Ratio | 1.30 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.34 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 2.38 |
| Price/Book | 14.95 |
| Price/Cash Flow | -29.10 |
| Per Share Data | |
| Earnings | -0.13 |
| Sales | 1.92 |
| Book Value | 0.31 |
| Cash Flow | -0.16 |
| Business Summary | |
|---|---|
| Biolase Inc is a medical technology company that develops, manufactures and markets laser systems for dental and medical applications. | |
| General Information | |
| 4 Cromwell
Irvine, CA 92618 |
|
| www.biolase.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 219 | |
| CEO: Federico Pignatelli | |
| Short Interest | |
| Current Month (Mil) | 3.16 |
| Previous Month (Mil) | 2.96 |
| Short Interest Ratio (Days) | 5.10 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -18.60 |
| Return on Investments | -58.00 |
| Profitability | |
| Gross Margin | 44.70 |
| EBIT Margin | -6.60 |
| Profit Margin | -9.40 |
Portfolios with BIOL
- Portfolio NameUser Type
- UserJaheer
Latest BIOL Headlines from TheStreet
- Biolase's CEO Discusses Q2 2012 Results - Earnings Call Transcript 08.09.12 | 01:08 am
Press Releases for BIOL
Partner Headlines for BIOL
- Morning Market Movers - Benzinga 10.03.12 | 09:10 am
- BIOLASE Comments on Recent Market Activity; Reiterates Guidance - Benzinga 06.22.12 | 01:06 pm
